Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Torsemide: a new loop diuretic

S F Fowler1, K M Murray

  • 1Department of Pharmacy Practice and Administration, College of Pharmacy, University of South Carolina, Columbia 29208, USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|August 15, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neonatal hyperoxia induces alterations in neurotrophin gene expression.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2015
Same author

Peptic ulcers in the elderly is a surgical disease.

American journal of surgery·2002
Same author

Personality type and success among female naval academy midshipmen.

Military medicine·2001
Same author

Etanercept in juvenile rheumatoid arthritis.

The Annals of pharmacotherapy·2001
Same author

Use of targeted anticytokine treatments in heart failure.

Circulation·2000
Same author

Breathing space.

American family physician·1998
Same journal

Pharmacists take on expanded role under new cholesterol guidelines.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Recent and anticipated novel drug approvals (Q2 2026 through Q1 2027).

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Optimizing transitions from direct factor Xa inhibitors to unfractionated heparin therapy.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Impact of pharmacist involvement on hospital sepsis response teams.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Attributes of centralized health-system specialty pharmacy clinics: A scoping review using the Donabedian model.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same journal

Zoliflodacin: A novel single-dose oral antibiotic for uncomplicated urogenital gonorrhea.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
See all related articles

Torsemide, a loop diuretic, effectively treats hypertension and edema in various conditions. While offering pharmacokinetic advantages, it may not significantly outperform other diuretics but can benefit non-responders.

Area of Science:

  • Pharmacology
  • Diuretic Therapy
  • Clinical Efficacy

Background:

  • Torsemide is a pyridine-sulfonylurea loop diuretic.
  • It acts on the thick ascending limb of the loop of Henle, inhibiting sodium and chloride reabsorption.

Purpose of the Study:

  • To review the pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage of torsemide.
  • To evaluate torsemide's role in treating hypertension and edema.

Main Methods:

  • Review of existing literature on torsemide.
  • Analysis of clinical trial data regarding efficacy and adverse effects.

Main Results:

  • Torsemide demonstrates high bioavailability, a long half-life, and prolonged activity.

Related Experiment Videos

  • Effective in treating hypertension, edema in chronic renal failure (CRF), hepatic dysfunction, and congestive heart failure (CHF).
  • Adverse effects are generally mild and transient, including orthostatic hypotension and fatigue.
  • Conclusions:

    • Torsemide is effective for hypertension and edema in specific patient populations.
    • Pharmacokinetic benefits may not always translate to superior clinical outcomes or cost-effectiveness.
    • It serves as a valuable alternative for patients unresponsive or intolerant to other loop diuretics.